SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-029436
Filing Date
2023-08-18
Accepted
2023-08-18 16:05:53
Documents
71
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1526948
2 ex3-15.htm EX-3.15 4865
3 ex10-1.htm EX-10.1 13130
4 ex31-1.htm EX-31.1 20418
5 ex31-2.htm EX-31.2 20414
6 ex32-1.htm EX-32.1 8134
7 ex32-2.htm EX-32.2 7986
8 form10-q_001.jpg GRAPHIC 25652
9 ex3-15_001.jpg GRAPHIC 288331
10 ex3-15_002.jpg GRAPHIC 467114
11 ex3-15_003.jpg GRAPHIC 351777
12 ex3-15_004.jpg GRAPHIC 296299
13 ex3-15_005.jpg GRAPHIC 369352
  Complete submission text file 0001493152-23-029436.txt   9945440

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE mrzm-20230630.xsd EX-101.SCH 54484
15 XBRL CALCULATION FILE mrzm-20230630_cal.xml EX-101.CAL 51316
16 XBRL DEFINITION FILE mrzm-20230630_def.xml EX-101.DEF 272473
17 XBRL LABEL FILE mrzm-20230630_lab.xml EX-101.LAB 432582
18 XBRL PRESENTATION FILE mrzm-20230630_pre.xml EX-101.PRE 350867
65 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1177997
Mailing Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458
Business Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458 561-935-9955
MARIZYME, INC. (Filer) CIK: 0001413754 (see all company filings)

IRS No.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53223 | Film No.: 231185917
SIC: 2834 Pharmaceutical Preparations